Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma
Clinical trial NCT04888429 · RECRUITING
Trial details
- NCT number
- NCT04888429
- Sponsor
- Qian Chu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2024-12-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.